Ad is loading...
DEMZX
Price
$21.01
Change
+$0.02 (+0.10%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

DEMZX vs RNWFX

Header iconDEMZX vs RNWFX Comparison
Open Charts DEMZX vs RNWFXBanner chart's image
Delaware Emerging Markets R6
Price$21.01
Change+$0.02 (+0.10%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
DEMZX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DEMZX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEMZX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. DEMZX (5.25B). DEMZX pays higher dividends than RNWFX: DEMZX (2.84) vs RNWFX (1.51). DEMZX was incepted earlier than RNWFX: DEMZX (9 years) vs RNWFX (23 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. DEMZX (2.00). DEMZX has a lower initial minimum investment than RNWFX: DEMZX (0) vs RNWFX (250). DEMZX annual gain was more profitable for investors over the last year : 14.29 vs. RNWFX (11.54). RNWFX (17.17) and DEMZX (16.54) have equivalent 5 years return.
DEMZXRNWFXDEMZX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD7.8547.099111%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.25B60.9B9%
Annual Yield % from dividends2.841.51188%
Returns for 1 year14.2911.54124%
Returns for 3 years-12.20-14.5584%
Returns for 5 years16.5417.1796%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics